Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
brytpunkterna enligt european committee on antimicrobial susceptibility testing (eucast) för känslighetstestning visas nedan.
the european committee on antimicrobial susceptibility testing (eucast) breakpoints for susceptibility testing are presented below.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
brytpunkter följande mic- brytpunkter har fastställts av the european committee on antimicrobial susceptibility testing (eucast):
breakpoints minimum inhibitory concentration (mic) breakpoints established by the european committee on antimicrobial susceptibility testing (eucast) are as follows:
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
de rekommenderade european committee for antimicrobial susceptibility testing (eucast) kliniska brytpunkterna för mic presenteras nedan:
the recommended european committee for antimicrobial susceptibility testing (eucast) mic clinical breakpoints are presented below:
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
följande minsta inhibitoriska koncentration (mic) brytpunkter är fastställda i samråd med european committee on antimicrobial susceptibility testing (eucast):
minimum inhibitory concentration (mic) breakpoints established by the european committee on antimicrobial susceptibility testing (eucast) are as follows:
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
1) accepterade sökanden att förslaget till produktresumé skulle uppdateras i tid för att inkludera brytpunkter fastställda av eucast (european committee on antimicrobial susceptibility testing).
in order to comply with the nfg on evaluation of medicinal products indicated for treatment of bacterial infections (cpmp/ ewp/ 558/ 95 rev.1), the applicant accepted that proposed spc should be updated in due time to include eucast breakpoints.
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
patienterna måste ha en bekräftad brca (breast cancer susceptibility)-mutation (antingen i könsceller eller i tumören) innan behandling med lynparza sätts in.
patients must have confirmation of a breast cancer susceptibility gene (brca) mutation (either germline or tumour) before lynparza treatment is initiated.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
kvalitativa data skall grundas på en tolkning i överensstämmelse med de epidemiologiska cut off-värden som presenteras på european committee on antimicrobial susceptibility testings (eucast) webbplats (http://www.eucast.org).
qualitative data shall be based on interpretation according to epidemiological cut-off values presented by the european committee on antimicrobial susceptibility testing (eucast) at: http://www.eucast.org
Ultimo aggiornamento 2014-11-03
Frequenza di utilizzo: 1
Qualità: